Research statistics

Noopept research: publications and trials

What has been published on Noopept: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Noopept works or is safe. For what it is and what the studies found, see the Noopept profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

85

Since 1997

Publications in 2026 so far

0

Through November 15, 2026

Human clinical research

10.7%

9 of 84 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

0

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

83.3%

63 animal · 7 in vitro · 0 computational

Records that only mention it

21

Not counted above

Status in the library: Research only. Groups: Cognitive and neurological peptides. 1 publications are not yet classified by study type.

What to keep in mind

  • Fewer than three randomized controlled trials are indexed.
  • More than 70% of the indexed publications are animal, cell or computational studies.
  • Not a peptide: it is shown for completeness and left out of every peptide total.

Publications by year

Noopept publications by year and evidence

1997, Preclinical (animal, in vitro, computational): 5 of 51998, Preclinical (animal, in vitro, computational): 2 of 21999, Preclinical (animal, in vitro, computational): 1 of 12000, Preclinical (animal, in vitro, computational): 3 of 32001, Preclinical (animal, in vitro, computational): 2 of 22002, Preclinical (animal, in vitro, computational): 6 of 72002, Reviews and meta-analyses: 1 of 72003, Preclinical (animal, in vitro, computational): 3 of 42003, Reviews and meta-analyses: 1 of 42004, Human clinical research: 1 of 22004, Preclinical (animal, in vitro, computational): 1 of 22005, Preclinical (animal, in vitro, computational): 3 of 32006, Preclinical (animal, in vitro, computational): 3 of 32007, Human clinical research: 1 of 62007, Preclinical (animal, in vitro, computational): 5 of 62008, Human clinical research: 3 of 72008, Preclinical (animal, in vitro, computational): 4 of 72009, Human clinical research: 2 of 52009, Preclinical (animal, in vitro, computational): 2 of 52009, Other and not yet classified: 1 of 52010, Preclinical (animal, in vitro, computational): 3 of 32011, Human clinical research: 1 of 52011, Preclinical (animal, in vitro, computational): 3 of 52011, Reviews and meta-analyses: 1 of 52012, Preclinical (animal, in vitro, computational): 3 of 32013, Preclinical (animal, in vitro, computational): 1 of 12014, Preclinical (animal, in vitro, computational): 4 of 42015, Preclinical (animal, in vitro, computational): 1 of 12016, Preclinical (animal, in vitro, computational): 2 of 22018, Human clinical research: 1 of 42018, Preclinical (animal, in vitro, computational): 2 of 42018, Reviews and meta-analyses: 1 of 42019, Preclinical (animal, in vitro, computational): 4 of 42020, Preclinical (animal, in vitro, computational): 1 of 12021, Preclinical (animal, in vitro, computational): 2 of 32021, Other and not yet classified: 1 of 32022, Preclinical (animal, in vitro, computational): 2 of 22023, Preclinical (animal, in vitro, computational): 1 of 12024, Preclinical (animal, in vitro, computational): 1 of 1Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0246819972003200920152024
Counted PubMed publications by year of first publication. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
199705005
199802002
199901001
200003003
200102002
200206107
200303104
200411002
200503003
200603003
200715006
200834007
200922015
201003003
201113105
201203003
201301001
201404004
201501001
201602002
201812104
201904004
202001001
202102013
202202002
202301001
202401001

Study types

Animal study63
Other clinical trial7
In vitro study7
Review4
Observational human study2
Editorial, letter or other1
Not yet classified1

Research areas

From MeSH major topics. A paper can be in several areas.

Cognitive health58
Neurological and mental health49
Metabolic health9
Cardiovascular8
Endocrinology8
Immune system3
Musculoskeletal3
Tissue repair3
Antimicrobial and infectious disease1
Oncology1
Reproductive and sexual health1

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. [The influence of self-massage combined with drug Noopept on the professional performance of teachers older.]

    Advances in gerontology = Uspekhi gerontologii · January 1, 2018 · Other clinical trial · cited 0 times

    PMID 30877834 · Human clinical research

  2. [Noopept in the treatment of mild cognitive impairment in patients with stroke].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2011 · Other clinical trial · cited 1 times

    PMID 22500312 · Human clinical research

  3. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.

    Neuroscience and behavioral physiology · March 1, 2009 · Other clinical trial · cited 17 times

    PMID 19234797 · DOI 10.1007/s11055-009-9128-4 · Human clinical research

  4. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2008 · Other clinical trial · cited 0 times

    PMID 18697252 · Human clinical research

  5. [Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2008 · Other clinical trial · cited 2 times

    PMID 19008801 · Human clinical research

  6. [Meteoadaptogenic properties of peptide drugs in healthy volunteers].

    Eksperimental'naia i klinicheskaia farmakologiia · November 1, 2007 · Other clinical trial · cited 2 times

    PMID 18318195 · Human clinical research

  7. [Interspecies differences of noopept pharmacokinetics].

    Eksperimental'naia i klinicheskaia farmakologiia · January 1, 2004 · Other clinical trial · cited 2 times

    PMID 15079908 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons.

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · May 1, 2003 · In vitro study · cited 65 times

    PMID 12711349 · DOI 10.1016/s0736-5748(03)00031-5 · In vitro studies

  2. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.

    Journal of psychopharmacology (Oxford, England) · November 8, 2006 · Animal study · cited 50 times

    PMID 17092975 · DOI 10.1177/0269881106071335 · Animal studies

  3. Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.

    Behavioural pharmacology · September 1, 1999 · Animal study · cited 36 times

    PMID 10780261 · DOI 10.1097/00008877-199909000-00013 · Animal studies

  4. Five Unapproved Drugs Found in Cognitive Enhancement Supplements.

    Neurology. Clinical practice · June 1, 2021 · Editorial, letter or other · cited 35 times · open access

    PMID 34484905 · DOI 10.1212/cpj.0000000000000960 · Commentary and other

  5. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.

    European journal of drug metabolism and pharmacokinetics · July 1, 1997 · Animal study · cited 30 times

    PMID 9358206 · DOI 10.1007/bf03189814 · Animal studies

Latest publications

  1. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity.

    Journal of pharmaceutical and biomedical analysis · September 16, 2024 · In vitro study · cited 0 times · open access

    PMID 39298839 · DOI 10.1016/j.jpba.2024.116474 · In vitro studies

  2. Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.

    Biotechnic & histochemistry : official publication of the Biological Stain Commission · March 22, 2023 · Animal study · cited 6 times

    PMID 36946173 · DOI 10.1080/10520295.2023.2187460 · Animal studies

  3. Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.

    International journal of molecular sciences · December 30, 2022 · Animal study · cited 9 times · open access

    PMID 36614135 · DOI 10.3390/ijms24010690 · Animal studies

  4. Effect of nootropic dipeptide noopept on CA1 pyramidal neurons involves α7AChRs on interneurons in hippocampal slices from rat.

    Neuroscience letters · October 3, 2022 · Animal study · cited 0 times

    PMID 36195298 · DOI 10.1016/j.neulet.2022.136898 · Animal studies

  5. Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats.

    Molecular neurobiology · July 9, 2021 · Animal study · cited 30 times

    PMID 34241806 · DOI 10.1007/s12035-021-02478-8 · Animal studies

  6. QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · June 11, 2021 · Animal study · cited 18 times

    PMID 34126240 · DOI 10.1016/j.ejps.2021.105909 · Animal studies

  7. Five Unapproved Drugs Found in Cognitive Enhancement Supplements.

    Neurology. Clinical practice · June 1, 2021 · Editorial, letter or other · cited 35 times · open access

    PMID 34484905 · DOI 10.1212/cpj.0000000000000960 · Commentary and other

  8. Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.

    Doklady. Biochemistry and biophysics · September 1, 2020 · In vitro study · cited 13 times

    PMID 33119829 · DOI 10.1134/s1607672920050129 · In vitro studies

  9. Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.

    Bulletin of experimental biology and medicine · November 27, 2019 · Animal study · cited 3 times

    PMID 31776952 · DOI 10.1007/s10517-019-04681-z · Animal studies

  10. MANAGEMENT OF AMNESTIC AND BEHAVIORAL DISORDERS AFTER KETAMINE ANESTHESIA.

    Georgian medical news · September 1, 2019 · Animal study · cited 4 times

    PMID 31687967 · Animal studies

Browse all 85 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: GVS-111; N-phenylacetyl-L-prolylglycine ethyl ester; Noopept; Omberacetam

((TITLE_ABS:"GVS-111" OR CHEM:"GVS-111" OR TITLE_ABS:"GVS111" OR CHEM:"GVS111") OR (TITLE_ABS:"N-phenylacetyl-L-prolylglycine ethyl ester" OR CHEM:"N-phenylacetyl-L-prolylglycine ethyl ester") OR (TITLE_ABS:"Noopept" OR CHEM:"Noopept") OR (TITLE_ABS:"Omberacetam" OR CHEM:"Omberacetam")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Noopept research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/noopept